Longevity
RCT June 29, 2026

Popular Rapamycin Drug May Actually Blunt Your Workout Gains

1

The Summary

This double-blind RCT randomized 40 sedentary older adults (aged 65-85) to receive either weekly rapamycin (6 mg) or a placebo for 13 weeks alongside a three-times-weekly home exercise program. While both groups improved their physical fitness, those taking the placebo showed greater improvements in lower-body strength (measured by chair-stand repetitions) than the rapamycin group. Additionally, the rapamycin group experienced a higher burden of minor side effects and one serious infection, suggesting that weekly rapamycin does not enhance—and may actually blunt—exercise adaptation in older adults.

2

Why this is interesting

Rapamycin is highly popular for its potential to extend healthy lifespan by mimicking calorie restriction. However, because exercise temporarily activates mTOR to build muscle, scientists wondered if blocking it with rapamycin would help or hurt workouts. This study provides a vital reality check: combining them actually hindered fitness gains. For health enthusiasts experimenting with these protocols, this suggests that biology and timing matter. Taking rapamycin alongside an active exercise program could counteract your hard work, highlighting the critical need for cautious, evidence-based dosing.